| | | | | Acquisition positions Catalent as premier partner for advanced biotherapeutics, now including cell therapy | |
|
| | | | Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions has announced agreement to acquire MaSTherCell, a leading, technology-focused cell therapy development and manufacturing partner.
In combination with Catalent’s deep experience in viral vector scale-up and production, MaSTherCell’s expertise in both autologous and allogeneic cell therapy development and manufacturing, will allow Catalent to be a full-service partner for CAR-T immunotherapies and beyond. |
|
|---|
| | |
| | MaSTherCell’s advanced capabilities will supplement Catalent’s industry-leading platform in biotechnologies including gene therapy, biomanufacturing, fill finish, clinical logistics and commercial supply, creating a comprehensive solution for advanced biotherapeutics. |
|
| |
| | | | | | | | | | MaSTherCell has a unique and comprehensive offering for Cell Therapy customers including a wide-range of expertise across cell types including MSCs, TILs, NKs, iPSCs and CAR-T. MaSTherCell has a clinical manufacturing facility in Gosselies, Belgium, where a large-scale commercial facility with dedicated commercial manufacturing space is under construction and expected to be fully commissioned in 2021. Additionally, MaSTherCell has just completed a new state-of-the-art clinical facility in Houston, Texas that is expected to be fully validated in Q2 2020, with preliminary planning underway for further expansions. |
|
|---|
| | |
| | Catalent will leverage its expertise in build-outs, scale-ups and commercial manufacturing as well as its resources to support MaSTherCell’s continued expansion in order to best support our customers and their patients. |
|
| |
| | | | | | | Learn More at an Upcoming Event | |
|
| | | | To learn more about our cell and gene capabilities, visit us at one of our upcoming events.
|
|
| |
| | | | | | Every molecule has a challenge. We have a solution. |
| | | | | | | | or call +1 877 891 9609 to speak with one of our experts today! |
| | |
| | | To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at sales@catalent.com, or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content. | | © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
